SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

SARS-CoV-2 is the trigger of MIS-C, which suggests that other viruses may trigger different forms of Kawasaki disease. The discovery of inborn errors of immunity underlying MIS-C would facilitate that of inborn errors of immunity to viruses underlying Kawasaki disease.

Mark S. Anderson | J. Casanova | J. Fellay | T. Maniatis | M. Gut | L. Notarangelo | J. Franco | S. Tangye | E. Haddad | P. Soler-Palacín | A. Šedivá | Y. Lau | Q. Pan-Hammarström | M. Kaforou | M. Levin | Shen-Ying Zhang | M. Papadaki | T. Kuijpers | G. Novelli | F. Al-Mulla | G. Blanchard-Rohner | L. Abel | Y. Itan | J. Milner | L. Hammarström | S. Henrickson | E. Bellos | A. Novelli | Erica G. Schmitt | M. Butte | A. Bolze | A. Puel | G. Aytekin | G. Casari | E. Andreakos | S. Okada | K. Imai | F. Haerynck | P. Lebon | A. Belot | I. Meyts | T. Mogensen | E. Jouanguy | H. Su | A. A. Abou Tayoun | A. Aiuti | P. Brodin | R. Halwani | I. Jordan | A. Schlüter | Y. Seeleuthner | R. Colobran | P. Bastard | Jacques G. Rivière | Danyel Lee | D. van de Beek | R. Pérez de Diego | V. Sancho-Shimizu | T. Özçelik | M. Arditi | S. Keles | D. Bogunovic | D. Bonnet | O. Yeşilbaş | E. Şevketoğlu | L. Alsina | C. Rodríguez-Gallego | Y. Bryceson | C. Aytekin | Qian Zhang | E. Hsieh | S. Bando | A. Volokha | F. Bajolle | J. Herberg | Q. Philippot | H. Abolhassani | A. Cobat | Z. Orbak | S. Mahmoudi | A. Pujol | O. Kasapcopur | B. Kandemir | G. Bayhan | D. Mansouri | N. Hatipoğlu | M. Shahrooei | A. Condino-Neto | L. Hoste | C. Flores | A. Karbuz | J. Celik | C. Biggs | B. Sözeri | M. Kwan | S. Aguilera-Albesa | D. Blázquez-Gamero | A. Gagro | J. Toubiana | A. Rodríguez-Palmero | Markéta Bloomfield | B. Drolet | Juan Valencia-Ramos | C. Lucas | A. Kılıç | A. Parlakay | S. Delafontaine | E. Erdeniz | Z. G. Gayretli Aydın | A. Yahşi | K. Béland | Laura Planas-Serra | M. Emiroğlu | O. Akcan | G. Alkan | S. Aytekin | Yahya Gul | Ş. Tüter Öz | Ş. Bozdemir | S. K. Yüksek | B. Gülhan | E. Özkan | Şehnaz Aydemir | Hasan Kapaklı | V. Yarar | A. Yosunkaya | H. Vatansev | S. H. Torun | S. Nepesov | T. Coşkuner | Y. Demirkol | M. Yildiz | Adam Klocperk | Laura Marque | J. Neves | A. Bousfiha | Saleh Almuhsen | A. Sobh | Weite Lei | Peng Zhang | Majistor Maglorius | Simon J. Pelham | Stephanie Menikou | Carolina Prando | A. Cavalcanti | O. Boyarchuk | Anastasiia Bondarenko | Yuriy Stepanovskiy | Lisa Arkin | M. Cooper | S. Chakravorty | S. Keleş | A. Klocperk | Levi Hoste | M. Bloomfield | P. Soler‐Palacín | S. Yüksek | Hassan Abolhassani | Evangelos Bellos | Carlos Flores | Mehmet Yildiz | Mehmet Yıldız | Aysun Yahši | Belgin Gülhan | Mohammad Shahrooei | Osman Yeşilbaş | Agustí Rodríguez-Palmero

[1]  anonymous,et al.  Addition of Nonauthor Collaborator Names of the French Covid-19 Paediatric Inflammation Consortium. , 2021, JAMA.

[2]  D. Hafler,et al.  Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children , 2021, Immunity.

[3]  A. Ramaswamy,et al.  Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Ramaswamy et al. 2021 Supplementary Tables , 2021 .

[4]  Mark S. Anderson,et al.  Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19 , 2021, bioRxiv.

[5]  E. Wherry,et al.  Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 , 2021, Science Immunology.

[6]  Hatem Al Rawahi,et al.  ACUTE APPENDICITIS MIMICKING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: CASE REPORT AND REVIEW OF THE LITERATURE , 2021, Journal of paediatrics and child health.

[7]  J. Casanova,et al.  Superantigenic TCR Vbeta 21.3 signature in Multisystem Inflammatory Syndrome in Children , 2021, medRxiv.

[8]  J. Karakaya,et al.  Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean , 2021, Clinical Rheumatology.

[9]  S. Özcan,et al.  Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children , 2021, International journal of rheumatic diseases.

[10]  B. Pulendran,et al.  Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine , 2021, The Journal of experimental medicine.

[11]  A. Belot,et al.  Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. , 2021, JAMA.

[12]  T. Ganzenmueller,et al.  A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19 , 2021, BMC Infectious Diseases.

[13]  Pedro Taffarel,et al.  Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients. , 2021, Archivos argentinos de pediatria.

[14]  M. Juan,et al.  Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease. , 2021, The Journal of clinical investigation.

[15]  G. Ghatasheh,et al.  COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region , 2021, Case reports in infectious diseases.

[16]  Jérémie F. Cohen,et al.  Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France , 2021, Journal of Clinical Immunology.

[17]  Ji Hyuk Lee,et al.  The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children , 2020, Journal of Korean medical science.

[18]  Jérémie F. Cohen,et al.  Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic. , 2021, Clinical chemistry.

[19]  E. Draper,et al.  Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance , 2020, The Lancet Child & Adolescent Health.

[20]  F. Haerynck,et al.  Multisystem inflammatory syndrome in children related to COVID-19: a systematic review , 2020, European Journal of Pediatrics.

[21]  J. Trück,et al.  Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland , 2021, Frontiers in Pediatrics.

[22]  J. Casanova,et al.  Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation , 2020, Med.

[23]  S. Hashimoto,et al.  Time Course of Coronary Artery Aneurysms in Kawasaki Disease. , 2020, The Journal of pediatrics.

[24]  E. Wherry,et al.  Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19) , 2020, Journal of the Pediatric Infectious Diseases Society.

[25]  Jérémie F. Cohen,et al.  Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  M. Levin,et al.  Multisystem Inflammatory Syndrome in Children: An International Survey , 2020, Pediatrics.

[27]  G. Blanchard-Rohner,et al.  Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 , 2020, Journal of the Pediatric Infectious Diseases Society.

[28]  M. H. Cheng,et al.  Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome , 2020, bioRxiv.

[29]  D. De Wolf,et al.  Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. , 2020, Circulation.

[30]  M. C. Magalhães-Barbosa,et al.  Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study , 2020, Jornal de Pediatria.

[31]  T. Cassidy-Smith,et al.  Multisystem Inflammatory Syndrome in Children , 2020, The Journal of Emergency Medicine.

[32]  D. Kim,et al.  Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea , 2020, Journal of Korean medical science.

[33]  D. Setiabudi,et al.  A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia , 2020, IDCases.

[34]  S. Renolleau,et al.  Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children , 2020, Circulation.

[35]  Todd A. Johnson,et al.  Association of an IGHV3-66 gene variant with Kawasaki disease , 2020, Journal of Human Genetics.

[36]  M. Levin.  Multisystem Inflammatory Syndrome in Children in the United States. Reply. , 2020, The New England journal of medicine.

[37]  P. Suryawanshi,et al.  Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) , 2020, The Indian Journal of Pediatrics.

[38]  J. Newburger,et al.  Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children , 2020, Journal of the American College of Cardiology.

[39]  M. S. Rezai,et al.  Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran , 2020, BMC Pediatrics.

[40]  C. Newton-Cheh,et al.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[41]  Pallavi,et al.  Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC) , 2020, The Indian Journal of Pediatrics.

[42]  Ayesha Javed,et al.  Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study , 2020, Cureus.

[43]  Fadi N Busaleh,et al.  Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia , 2020, Cureus.

[44]  J. McDonagh,et al.  Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) , 2020, Journal of clinical medicine.

[45]  P. Ishimine,et al.  Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature , 2020, The Journal of Emergency Medicine.

[46]  M. H. Cheng,et al.  Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.

[47]  K. Ludwikowska,et al.  The first case of pediatric inflammatory multisystem syndrome (PIMS-TS) in Poland, complicated by giant coronary artery aneurysms. , 2020, Kardiologia polska.

[48]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[49]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[50]  D. Hsu,et al.  Cardiac Abnormalities Seen in Pediatric Patients During the SARS‐CoV2 Pandemic: An International Experience , 2020, Journal of the American Heart Association.

[51]  S. Tibby,et al.  A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process , 2020, The Lancet Child & Adolescent Health.

[52]  S. Patnaik,et al.  Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid , 2020, The Indian Journal of Pediatrics.

[53]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.

[54]  A. Tremoulet,et al.  Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America. , 2020, The Pediatric infectious disease journal.

[55]  R. Yeung,et al.  Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names , 2020, Canadian Medical Association Journal.

[56]  M. M. van der Zalm,et al.  Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19. , 2020, The Pediatric infectious disease journal.

[57]  Álvaro Freitas Moreira,et al.  Multisystem inflammatory syndrome in children: A systematic review , 2020, EClinicalMedicine.

[58]  J. Rossano,et al.  Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States , 2020, Journal of the American College of Cardiology.

[59]  V. Ziaee,et al.  Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran , 2020, Epidemiology and Infection.

[60]  G. Izquierdo,et al.  Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic , 2020, International Journal of Infectious Diseases.

[61]  Sohan Seth,et al.  Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.

[62]  M. C. Justino,et al.  MULTISYSTEM INFLAMMATORY SYNDROME IN A CHILD ASSOCIATED WITH CORONAVIRUS DISEASE 19 IN THE BRAZILIAN AMAZON: FATAL OUTCOME IN AN INFANT , 2020, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.

[63]  M. McCulloch,et al.  Multisystem inflammatory syndrome in children in South Africa , 2020, The Lancet Child & Adolescent Health.

[64]  J. R. Rebello Pinho,et al.  SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome , 2020, The Lancet Child & Adolescent Health.

[65]  J. Newburger,et al.  Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.

[66]  M. Alves,et al.  Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belém, Pará, Brazil. , 2020, The Pediatric infectious disease journal.

[67]  M. Malim,et al.  Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.

[68]  K. Reilly,et al.  COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[69]  P. Bobhate,et al.  Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India , 2020, Indian Pediatrics.

[70]  P. Agrawal,et al.  Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation , 2021 .

[71]  N. Sultana,et al.  Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan , 2020, The Lancet Child & Adolescent Health.

[72]  S. Kabir,et al.  Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19 , 2020, European heart journal cardiovascular Imaging.

[73]  A. Ramanan,et al.  Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome — Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children , 2020, Indian Pediatrics.

[74]  E. Chow,et al.  Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review , 2020, The Journal of Pediatrics.

[75]  E. Chow,et al.  Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review , 2020, The Journal of Pediatrics.

[76]  Kenan W. D. Stern,et al.  Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children , 2020, The Journal of Pediatrics.

[77]  G. Di Sante,et al.  Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19. , 2020, The Pediatric infectious disease journal.

[78]  K. Sullivan,et al.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.

[79]  J. R. Contreras,et al.  Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain , 2020, Clinical Infectious Diseases.

[80]  L. Henderson,et al.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 , 2020, Arthritis & rheumatology.

[81]  J. Chou,et al.  Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. , 2020, The Journal of clinical investigation.

[82]  D. De Backer,et al.  Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report , 2020, Frontiers in Medicine.

[83]  P. Palma,et al.  The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 , 2020, Cell.

[84]  P. Davies,et al.  Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.

[85]  N. Rezaei,et al.  Hyperinflammatory shock related to COVID‐19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran , 2020, Journal of paediatrics and child health.

[86]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, medRxiv.

[87]  A. Šedivá,et al.  Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19 , 2020, Frontiers in Immunology.

[88]  L. Titomanlio,et al.  Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis , 2020, The Lancet Child & Adolescent Health.

[89]  U. Löbel,et al.  Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. , 2020, JAMA neurology.

[90]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[91]  David R. Holtgrave,et al.  Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.

[92]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[93]  A. Bruckner,et al.  Focus on "COVID Toes". , 2020, JAMA dermatology.

[94]  D. Eytan,et al.  PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AND HYPOCOMPLEMENTEMIA FOLLOWING SARS-COV-2 INFECTION. , 2020, The Pediatric infectious disease journal.

[95]  Andrew R. Leach,et al.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.

[96]  J. Tang,et al.  COVID‐19 multisystem inflammatory syndrome in three teenagers with confirmed SARS‐CoV‐2 infection , 2020, Journal of medical virology.

[97]  J. Yáñez,et al.  Covid-19 in Peru: from supervised walks for children to the first case of Kawasaki-like syndrome , 2020, BMJ.

[98]  K. Davidson,et al.  Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 Infection , 2020, The Journal of Pediatrics.

[99]  B. Scholefield,et al.  Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital , 2020, Pediatric Cardiology.

[100]  G. Carcelain,et al.  Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort , 2020, Annals of the Rheumatic Diseases.

[101]  E. Blondiaux,et al.  Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series , 2020, Radiology.

[102]  P. Zachariah,et al.  Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. , 2020, JAMA.

[103]  B. McCrindle,et al.  SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease? , 2020, JAMA.

[104]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[105]  U. Erenberk,et al.  Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID‐19 in a 3‐year‐old girl , 2020, Dermatologic therapy.

[106]  P. Zachariah,et al.  Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases , 2020, Gastroenterology.

[107]  Jérémie F. Cohen,et al.  Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study , 2020, BMJ.

[108]  C. Delacourt,et al.  SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[109]  J. Casanova,et al.  The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? , 2020, Human Genetics.

[110]  E. Mahé,et al.  Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[111]  Yosikazu Nakamura,et al.  Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. , 2020, The Journal of pediatrics.

[112]  P. Horby,et al.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.

[113]  L. Bonnemains,et al.  Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic , 2020, Circulation.

[114]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[115]  Russell M Viner,et al.  Kawasaki-like disease: emerging complication during the COVID-19 pandemic , 2020, The Lancet.

[116]  Jacques Fellay,et al.  A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection , 2020, Cell.

[117]  E. Parodi,et al.  SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children , 2020, Pediatrics.

[118]  J. Orange,et al.  The Growing Spectrum of Human Diseases Caused by InheritedCDC42 Mutations , 2020, Journal of Clinical Immunology.

[119]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[120]  K. Brengel-Pesce,et al.  Type I IFN immunoprofiling in COVID-19 patients , 2020, Journal of Allergy and Clinical Immunology.

[121]  Yae-Jean Kim,et al.  Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic , 2020, Journal of Korean medical science.

[122]  J. Casanova,et al.  Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories. , 2020, Annual review of pathology.

[123]  S. Maskatia,et al.  COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.

[124]  A. Rawat,et al.  Immunogenetics of Kawasaki disease , 2020, Clinical Reviews in Allergy & Immunology.

[125]  Mindy S Lo.  A framework for understanding Kawasaki disease pathogenesis. , 2020, Clinical immunology.

[126]  S. Canna,et al.  Pediatric Hemophagocytic Lymphohistiocytosis (HLH). , 2020, Blood.

[127]  K. Wylie,et al.  A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease. , 2020, The Journal of infectious diseases.

[128]  S. Tangye,et al.  Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation , 2020, Journal of Clinical Immunology.

[129]  S. Tangye,et al.  Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. , 2020, Blood.

[130]  Ivan K. Chinn,et al.  A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function , 2019, The Journal of experimental medicine.

[131]  Xiaochen Xie,et al.  The T helper type 17/regulatory T cell imbalance was associated with Ras‐GTPase overexpression in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease , 2019, Immunology.

[132]  D. Lewis,et al.  Severe autoinflammation in four patients with C-terminal variants in CDC42 successfully treated with IL-1β inhibition. , 2019, The Journal of allergy and clinical immunology.

[133]  P. Langford,et al.  Kawasaki Disease: The Role of Immune Complexes Revisited , 2019, Front. Immunol..

[134]  L. Jung,et al.  Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition , 2019, Pediatric Rheumatology.

[135]  J. Burns,et al.  How Should We Classify Kawasaki Disease? , 2018, Front. Immunol..

[136]  J. Newburger,et al.  Kawasaki Disease , 2018, Pediatrics in Review.

[137]  Yosikazu Nakamura,et al.  Kawasaki disease: epidemiology and the lessons from it , 2017, International journal of rheumatic diseases.

[138]  M. Stringer.  Acute appendicitis , 2017, Journal of paediatrics and child health.

[139]  C. Wouters,et al.  How Viruses Contribute to the Pathogenesis of Hemophagocytic Lymphohistiocytosis , 2017, Front. Immunol..

[140]  Todd A. Johnson,et al.  A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease , 2017, Journal of Human Genetics.

[141]  M. Levin,et al.  Dissecting Kawasaki disease: a state-of-the-art review , 2017, European Journal of Pediatrics.

[142]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[143]  J. Newburger,et al.  Kawasaki Disease. , 2013, Journal of the American College of Cardiology.

[144]  G. Hajishengallis,et al.  DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates , 2015, Science Translational Medicine.

[145]  P. Lebon,et al.  Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study". , 2014, Pathologie-biologie.

[146]  Yusuke Nakamura,et al.  A genome-wide association study identifies three new risk loci for Kawasaki disease , 2012, Nature Genetics.

[147]  Fuu-Jen Tsai,et al.  Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis , 2012, Nature Genetics.

[148]  G. Janka,et al.  Familial and acquired hemophagocytic lymphohistiocytosis. , 2012, Annual review of medicine.

[149]  Tien Yin Wong,et al.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease , 2011, Nature Genetics.

[150]  Y. Zu,et al.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease , 2010, Clinical and experimental immunology.

[151]  O. Ramilo,et al.  CONCOMITANT RESPIRATORY VIRAL INFECTIONS IN CHILDREN WITH KAWASAKI DISEASE , 2010, The Pediatric infectious disease journal.

[152]  R. Holman,et al.  Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007 , 2010, The Pediatric infectious disease journal.

[153]  R. Klar,et al.  Kawasaki disease lacks association with human coronavirus NL63 and human bocavirus. , 2009, The Pediatric infectious disease journal.

[154]  Yoshihiro Onouchi,et al.  Molecular Genetics of Kawasaki Disease , 2009, Pediatric Research.

[155]  J. Kanegaye,et al.  Recognition of a Kawasaki Disease Shock Syndrome , 2009, Pediatrics.

[156]  P. Bruhns,et al.  Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.

[157]  Yusuke Nakamura,et al.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.

[158]  K. Holmes,et al.  Blinded Case‐Control Study of the Relationship between Human Coronavirus NL63 and Kawasaki Syndrome , 2006, The Journal of infectious diseases.

[159]  J. Burns,et al.  Human Coronavirus NL63 Is Not Detected in the Respiratory Tracts of Children with Acute Kawasaki Disease , 2005, The Journal of infectious diseases.

[160]  J. Casanova,et al.  Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[161]  K. Gauvreau,et al.  Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis , 2005, Pediatrics.

[162]  E. Shapiro,et al.  Association between a Novel Human Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.

[163]  J. Burns,et al.  Kawasaki syndrome , 2004, The Lancet.

[164]  L. Haines,et al.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children. , 2003, The Cochrane database of systematic reviews.

[165]  H. Jäck,et al.  IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. , 1997, Journal of Immunology.

[166]  O. Teixeira,et al.  Long-term consequences of Kawasaki disease. , 1997, Circulation.

[167]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[168]  G. Lombard,et al.  Pediatric Intensive Care Unit , 2009 .

[169]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.

[170]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].